“…Despite this being effective, NK/T‐cell lymphoma has a high recurrence rate, reaching 50%. It is associated with a high mortality if not managed timely, resulting in 5‐year survival rates of 70% and 30% in the early and late stages of disease, respectively 1,4 …”